Cargando…
Effects of different doses of methylprednisolone on clinical outcomes in patients with severe community-acquired pneumonia: a study protocol for a randomized controlled trial
BACKGROUND: The specific use of methylprednisolone in severe community-acquired pneumonia (SCAP) has not yet formed a consensus. It is not clear whether the clinical efficacy of methylprednisolone in SCAP is dose-dependent, and how to balance the best efficacy with the least complications. The aim o...
Autores principales: | Hong, Shukun, Wang, Hongye, Liu, Jian, Qiao, Lujun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123754/ https://www.ncbi.nlm.nih.gov/pubmed/35598005 http://dx.doi.org/10.1186/s13063-022-06404-8 |
Ejemplares similares
-
Effects of different doses of methylprednisolone therapy on acute respiratory distress syndrome: results from animal and clinical studies
por: Hong, Shukun, et al.
Publicado: (2022) -
Low‐dose versus high‐dose methylprednisolone for children with severe Mycoplasma pneumoniae pneumonia (MCMP): Study protocol for a randomized controlled trial
por: Xu, Baoping, et al.
Publicado: (2018) -
A systematic review and meta-analysis of glucocorticoids treatment in severe COVID-19: methylprednisolone versus dexamethasone
por: Hong, Shukun, et al.
Publicado: (2023) -
The roles of methylprednisolone treatment in patients with COVID-19: A systematic review and meta-analysis
por: Hong, Shukun, et al.
Publicado: (2022) -
Low-dose methylprednisolone treatment in critically ill patients with severe community-acquired pneumonia
por: Meduri, G. Umberto, et al.
Publicado: (2022)